Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

NCT05027633 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma
the Nasal Cavity
Paranasal Sinuses

Interventions

DRUG: Pembrolizumab
DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

M.D. Anderson Cancer Center